Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 3, 2005, Pages 1177-1180

  Ying, C ^a   Holy A ^b   Hockova D ^b   Havlas, Z ^b   De Clercq, E ^a   Neyts, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIAMINO 6 [2 (PHOSPHONOMETHOXY)ETHOXY]PYRIMIDINE; 5 CYANO 2,4 DIAMINO 6 [2 (PHOSPHONOMETHOXY)ETHOXY]PYRIMIDINE; ACYCLIC NUCLEOSIDE; ADEFOVIR; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG POTENCY; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

ADENINE; ANTIVIRAL AGENTS; HEPATITIS B VIRUS; NUCLEOSIDES; PHOSPHONIC ACIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 14744274964     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.3.1177-1180.2005     Document Type: Article

References (12)

1. Balzarini, J., C. Pannecouque, E. De Clercq, S. Aquaro, C.-F. Perno, H. Egberink, and A. Holy. 2002. Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates. Antimicrob. Agents Chemother. 46:2185-2193.
2. Balzarini, J., S. Aquaro, C.-F. Perno, M. Witvrouw, A. Holý, and E. De Clercq. 1996. Activity of the (R)-enantiomers of 9-(2-phosphonyl- methoxypropyl)adenine and 9-(2-phosphonyl-methoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Biochem. Biophys. Res. Commun. 219:337-341.
3. Balzarini, J., A. Holý, J. Jindrich, L. Naesens, R. Snoeck, D. Schols, and E. De Clercq. 1993. Differential antiherpesvirus and antiretrovirus effects of the (5) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob. Agents Chemother. 37:332-338.
4. Hocková, D., A. Holý, M. Masojidkova, G. Andrei, R. Snoeck, E. De Clercq, and J. Balzarini. 2003. 5-Substituted-2,4-diamino-6-[2- (phosphonomethoxy)-ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity. J. Med. Chem. 46:5064-5073.
5. Hocková, D., A. Holy, M. Masojidkova, G. Andrei, R. Snoeck, E. De Clercq, and J. Balzarini. 2004. Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds. Bioorg. Med. Chem. 15:3197-3202.
6. Holy, A., I. Votruba, M. Masojidkova, G. Andrei, R. Snoeck, L. Naesens, E. De Clercq, and J. Balzarini. 2002. 6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity. J. Med. Chem. 45:1918-1929.
7. Holy, A. 2003. Phosphonomethoxyalkyl analogs of nucleotides. Curr. Pharm. Des. 9:2567-2592.
8. Ladner, S. K., M. J. Otto, C. S. Barker, K. Zaifert, G.-H. Wang, J.-T. Guo, C. Seeger, and R. W. King. 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41:1715-1720.
9. Ladner, S. K., T. J. Miller, and R. W. King. 1998. The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2′-deoxy-3′-thiacytidine and a reduced ability to synthesize viral DNA. Antimicrob. Agents Chemother. 42:2128-2131.
10. Yadav, V., and C. K. Chu. 2004. Molecular mechanisms of adefovir sensitivity and resistance in HBV polymerase mutants: a molecular dynamics study. Bioorg. Med. Chem. Lett. 14:4313-4317.
11. Ying, C., E. De Clercq, W. Nicholson, P. Furman, and J. Neyts. 2000. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, PENCICLOVIR AND LOBUCAVIR. J. Viral Hepat. 7:161-165.
12. Ying, C., E. De Clercq, and J. Neyts. 2003. Selective inhibitors of hepatitis B virus replication. Curr. Med. Chem. Anti-Infect. Agents 2:227-240.